Status:

TERMINATED

Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome

Lead Sponsor:

Michael Cotten

Conditions:

Hypoplastic Left Heart Syndrome

Eligibility:

All Genders

Up to 2 years

Phase:

PHASE1

Brief Summary

Further study details as provided by Duke University: Purpose: To evaluate the feasibility and safety of collecting and infusing autologous umbilical cord blood (UCB) in newborn infants with hypoplas...

Detailed Description

The purpose of this pilot study is to evaluate the safety and feasibility of infusions of autologous (the patient's own)umbilical cord blood cells in neonates with hypoplastic left heart syndrome. Thi...

Eligibility Criteria

Inclusion

  • Infants \> 35 weeks gestational age.
  • Diagnosis: Hypoplastic Left Heart Syndrome.
  • Autologous umbilical cord blood available with a minimum total nucleated cell dose of 1 x 10e7 cells/kg.
  • Parental Consent.

Exclusion

  • Chromosomal anomalies identified before the time of infusion.
  • Chromosomal anomalies or congenital anomalies that would prohibit clinicians from initiating surgical repair of the congenital heart defect.
  • Infant is determined by clinical staff to be non-viable and will not receive aggressive care. (No member on the study team will be involved in determining the viability of the neonate.)
  • Autologous umbilical cord blood unit has any of the following:
  • Total nuclear cell count \< 1 x 10e7.
  • Positive maternal infectious serology (except CMV).
  • Evidence of infectious contamination of the cord blood unit.
  • Evidence of genetic disease.
  • Unable to obtain parental consent.
  • Mother \< 18 years old.

Key Trial Info

Start Date :

September 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 15 2016

Estimated Enrollment :

7 Patients enrolled

Trial Details

Trial ID

NCT01445041

Start Date

September 1 2011

End Date

April 15 2016

Last Update

May 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Duke University

Durham, North Carolina, United States, 27710